Dolby Laboratories (NYSE: DLB) insider files to sell 4,500 shares under Rule 144

Rhea-AI Filing Summary

Dolby Laboratories insider plans Rule 144 share sale. A holder has filed a notice to sell 4,500 shares of common stock of Dolby Laboratories under Rule 144. The proposed sale, through Morgan Stanley Smith Barney LLC on the NYSE, has an aggregate market value of $304,035.75 based on the filing information. The shares were acquired on 12/01/2025 via a stock option exercise from the issuer for cash, and the same number of shares is slated for sale. The filing notes that 60,845,846 shares of the issuer’s common stock were outstanding, providing context for the size of this planned transaction.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4500	304035.75	60845846	12/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/01/2025	Stock Option Exercise	ISSUER			4500	12/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for DLB disclose?

The filing discloses that a holder plans to sell 4,500 shares of Dolby Laboratories common stock under Rule 144 through a broker on the NYSE.

How many Dolby Laboratories (DLB) shares are planned to be sold?

The notice covers a proposed sale of 4,500 shares of Dolby Laboratories common stock.

What is the aggregate market value of the DLB shares to be sold?

The 4,500 shares of Dolby Laboratories common stock have an aggregate market value of $304,035.75 as stated in the filing.

How and when were the Dolby Laboratories shares being sold acquired?

The 4,500 shares were acquired on 12/01/2025 via a stock option exercise from the issuer, paid in cash.

Which broker is handling the planned DLB share sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the planned sale on the NYSE.

How many Dolby Laboratories shares were outstanding according to the filing?

The filing reports that 60,845,846 shares of Dolby Laboratories common stock were outstanding, which is a baseline figure for the company’s equity.